Неврология, нейропсихиатрия, психосоматика (May 2023)
New pharmaconutraceutical Chondroguard®TRIO for the prevention of musculoskeletal diseases and nutritional support for patients with osteoarthritis and nonspecific back pain: an assessment of clinical options. Resolution of the Multidisciplinary Expert Council
- Al. B. Danilov,
- A. M. Lila,
- Yo. N. Majidova,
- O. A. Gromova,
- O. N. Tkacheva,
- I. V. Sarvilina,
- A. Yu. Kochish,
- A. G. Nazarenko,
- N. V. Zagorodniy,
- T. B. Minasov,
- L. I. Alekseeva,
- E. A. Taskina,
- Yu. V. Kotovskaya,
- E. N. Dudinskaya,
- A. V. Rozanov,
- E. Yu. Solovieva,
- O. A. Shavlovskaya,
- M. N. Sharov,
- P. R. Kamchatnov,
- A. P. Rachin,
- E. R. Barantsevich,
- D. A. Iskra,
- E. Z. Yakupov,
- F. I. Devlikamova,
- A. E. Barulin,
- M. V. Nesterova,
- T. G. Sakovets,
- A. N. Barinov,
- I. N. Dolgova,
- N. V. Zabolotskikh,
- E. V. Zonova,
- L. A. Shchepankevich,
- V. A. Parfenov,
- A. T. Dzhurabekova,
- S. Z. Khakimova
Affiliations
- Al. B. Danilov
- I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
- A. M. Lila
- V.A. Nasonova Research Institute of Rheumatology; Russian Medical Academy of Continuing Professional Education
- Yo. N. Majidova
- Tashkent Pediatric Medical Institute
- O. A. Gromova
- Federal Research Center “Computer Science and Control”, Russian Academy of Sciences
- O. N. Tkacheva
- Russian Clinical and Research Center of Gerontology, N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
- I. V. Sarvilina
- Medical Center Novomeditsina LLC
- A. Yu. Kochish
- Russian Scientific Research Institute of Traumatology and Orthopedics named after R.R. Vreden
- A. G. Nazarenko
- N.N. Priorov National Medical Research Center of Traumatology and Orthopedics
- N. V. Zagorodniy
- N.N. Priorov National Medical Research Center of Traumatology and Orthopedics
- T. B. Minasov
- Bashkir State Medical University, Ministry of Health of Russia
- L. I. Alekseeva
- V.A. Nasonova Research Institute of Rheumatology
- E. A. Taskina
- V.A. Nasonova Research Institute of Rheumatology
- Yu. V. Kotovskaya
- Russian Clinical and Research Center of Gerontology, N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
- E. N. Dudinskaya
- Russian Clinical and Research Center of Gerontology, N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
- A. V. Rozanov
- Russian Clinical and Research Center of Gerontology, N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
- E. Yu. Solovieva
- N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
- O. A. Shavlovskaya
- International University of Restorative Medicine
- M. N. Sharov
- A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia
- P. R. Kamchatnov
- N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
- A. P. Rachin
- National Association of Experts in Comorbid Neurology
- E. R. Barantsevich
- Acad. I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia
- D. A. Iskra
- Saint Petersburg State Pediatric Medical University, Ministry of Health of Russia
- E. Z. Yakupov
- Neuroclinic of Professor Yakupov
- F. I. Devlikamova
- Kazan State Medical Academy, branch of Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia
- A. E. Barulin
- Volgograd State Medical University, Ministry of Health of Russia
- M. V. Nesterova
- Ural State Medical University, Ministry of Health of Russia
- T. G. Sakovets
- Kazan State Medical University, Ministry of Health of Russia
- A. N. Barinov
- Medical Academy of JSC “MEDSI” Group of Companies”
- I. N. Dolgova
- Stavropol State Medical University, Ministry of Health of Russia
- N. V. Zabolotskikh
- Kuban State Medical University, Ministry of Health of Russia
- E. V. Zonova
- Novosibirsk State Medical University, Ministry of Health of Russia
- L. A. Shchepankevich
- Novosibirsk State Medical University, Ministry of Health of Russia
- V. A. Parfenov
- I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
- A. T. Dzhurabekova
- Samarkand State Medical University
- S. Z. Khakimova
- Samarkand State Medical University
- DOI
- https://doi.org/10.14412/2074-2711-2023-2-134-146
- Journal volume & issue
-
Vol. 15,
no. 2
pp. 134 – 146
Abstract
In recent decades, there has been an increase in the prevalence and medical and social burden of osteoarthritis (OA) and nonspecific back pain in all countries of the world. The First Multidisciplinary Bilateral Russia-Uzbekistan Expert Council presented innovations in the prognosing, personalized prevention and adjuvant therapy of degenerative-dystrophic diseases of the joints and spine, the evidence base for the effectiveness and safety of the use of drugs that modify the course of OA (Disease-modifying osteoarthritis drugs, DMOADs): chondroitin sulfate, glucosamine sulfate, undenatured type II collagen for adjuvant pharmaconutraceutical support – prevention and adjuvant therapy (treatment) of OA and nonspecific lumbosacral pain. The expert counsil resolution presents an optimized algorithm for the management, prevention and adjuvant therapy of OA and non-specific back pain, maintaining the function of healthy joints after intense physical activity with the inclusion of the drug Chondroguard solution for intra-articular and intramuscular administration (INN – chondroitin sulfate) and a new pharmaconutraceutical from the DMOADs group – TRIO trademark Chondroguard® (Chondroguard®TRIO).
Keywords
- osteoarthritis
- lower back pain
- pharmaconutraceutical
- chondroitin sulfate
- glucosamine sulfate
- undenatured type ii collagen
- chondroguard ®trio
